Semaglutide with B12 is usually a compounded medication, so monthly cost varies by pharmacy, prescribed amount, state rules, and whether clinical care is included 9. It is usually self-pay because compounded drugs are not FDA-approved 1, 9. At Chia, compounded semaglutide injection plans currently start at $249/month; we do not list a semaglutide-B12 combination.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How much does semaglutide with B12 usually cost?
Semaglutide with B12 does not have one standard monthly price because it is usually a compounded product rather than an FDA-approved brand 1, 9. The useful comparison is the total cost for one month of medication and clinical care, not just the vial price.
The monthly total may include medication, clinician review, follow-up visits, portal messaging, syringes, shipping, and pharmacy handling. Some programs bill these separately. Our guide to semaglutide cost explains why insurance, cash-pay prices, and compounded options can look very different.
What the monthly price may include
| Cost item | Why it can change the total | Question to ask |
|---|---|---|
| Medication | The pharmacy, formulation, vial size, and prescribed amount may affect price. | Is medication included for the full month? |
| Clinician review | A prescriber should review health history, medications, and safety factors before writing a prescription. | Is licensed clinician review included? |
| Follow-up care | GLP-1 side effects and treatment changes can require follow-up 1. | Can I contact the care team between visits? |
| Shipping and supplies | Cold shipping and injection supplies may be included or billed separately. | Are shipping and supplies included? |
| Membership fees | Some telehealth programs charge a separate recurring care fee. | Is this the real monthly total? |
Why dose, pharmacy, and state rules can change the price
Costs can change when the prescribed amount changes, when a pharmacy uses a different vial size, or when state rules affect telehealth prescribing and shipping. FDA-approved Wegovy labeling begins at 0.25 mg once weekly for the first four weeks and is titrated over time toward maintenance dosing when tolerated 2. That is label information, not personal dosing advice, but it shows why GLP-1 costs can change during treatment.
Why advertised prices may not show the full monthly cost
Before comparing programs, ask whether the quoted amount includes all clinical care, medication, supplies, shipping, and dose changes. FDA also warns consumers to avoid online sellers that skip licensed-clinician screening or do not require a valid prescription 1.
What is semaglutide with B12?
Semaglutide is a GLP-1 receptor agonist. It acts on pathways involved in appetite, stomach emptying, and blood sugar regulation 3. Semaglutide with B12 usually refers to a compounded formula that combines semaglutide with vitamin B12 9.
Semaglutide as a GLP-1 receptor agonist
Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus, but those FDA-approved products have different approved uses and forms 3. Wegovy is an injection labeled for chronic weight management in people who meet its criteria, alongside a reduced-calorie diet and increased physical activity 2. Rybelsus is an oral tablet for adults with type 2 diabetes, while Ozempic is an injection for type 2 diabetes and certain cardiovascular and kidney-risk indications 3.
Why some compounded formulas include vitamin B12
Vitamin B12 is needed for red blood cell formation, nerve function, and DNA synthesis 4. Some compounders use cyanocobalamin or methylcobalamin in a semaglutide formula 9. Adding B12 does not make that product an FDA-approved semaglutide brand, and it does not establish better weight-loss results 1, 9.
What is known and not known about B12 for weight loss
The main weight-loss evidence is for semaglutide as studied in clinical trials, not for compounded semaglutide-B12 combinations. In the STEP 1 trial, adults without diabetes received 2.4 mg semaglutide subcutaneously once weekly plus lifestyle intervention for 68 weeks. Mean weight change was -14.9% with semaglutide and -2.4% with placebo; nausea and diarrhea were common, and gastrointestinal events led some participants to stop treatment 5. Individual results vary. Compounded formulations do not have FDA-evaluated outcomes data 1.
Is semaglutide with B12 FDA-approved?
Semaglutide with B12 is not an FDA-approved brand product. It is typically compounded, and FDA states that unapproved GLP-1 drugs do not undergo its premarket review for safety, effectiveness, or quality 1.
Which semaglutide products are FDA-approved?
FDA-approved semaglutide products include Ozempic, Wegovy, and Rybelsus. Each has its own approved indication, dosage form, and prescribing information 2, 3. Wegovy is the semaglutide brand labeled for chronic weight management for patients who meet label criteria 2.
How does compounded semaglutide differ from brand products?
Compounded semaglutide is prepared by a compounding pharmacy for a patient-specific prescription. It is not a generic version of Ozempic or Wegovy and should not be described as the same as either brand. FDA has identified concerns with unapproved GLP-1 products, including dosing errors, multi-dose vial handling, shipping and storage problems, fraudulent products, and ingredient-quality concerns 1.
What affects the out-of-pocket cost?
Out-of-pocket semaglutide cost depends on the product, diagnosis, insurance plan, pharmacy, prescribed amount, and care model. The most important comparison is often the ongoing monthly total, including medication and support.
- Brand-name versus compounded medication: FDA-approved products may be covered by insurance or savings programs; compounded products are often self-pay 2, 3, 9.
- Insurance and prior authorization: coverage can differ for type 2 diabetes, obesity, overweight with a related condition, and cardiovascular-risk indications 2, 3.
- Treatment changes over time: the prescribed amount and pharmacy supply may affect the total price.
- Care fees: some telehealth services separate membership or follow-up fees from medication pricing.
- Shipping and supplies: cold shipping, syringes, and clinician messaging may be included or billed separately.
Price is a major part of access. A 2023 cost-effectiveness model of oral semaglutide in Chinese adults with type 2 diabetes found that its results were highly sensitive to annual drug cost 6. ICER’s 2025 obesity evidence report also described affordability and budget impact as important issues for semaglutide and tirzepatide, even where evidence supported benefits from the studied FDA-approved products 7.
3-min quiz
Considering semaglutide through licensed care?
At Chia, compounded semaglutide injection plans currently start at $249/month. Start with an online health questionnaire and licensed US provider review; a prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
Will insurance cover semaglutide or semaglutide with B12?
Insurance coverage is more common for FDA-approved semaglutide products than for compounded semaglutide with B12, but each plan sets its own rules 2, 3, 9. Coverage may depend on diagnosis, formulary placement, prior authorization, deductibles, and whether weight-management medicines are excluded.
Ozempic and Rybelsus are FDA-approved for type 2 diabetes, while Wegovy is labeled for chronic weight management in eligible patients and for certain cardiovascular-risk uses 2, 3. Compounded semaglutide with B12 is commonly self-pay because it is not an FDA-approved product 1, 9.
Questions to ask your insurer before starting
- Is semaglutide covered for my diagnosis?
- Which product and dosage form is on my formulary?
- Do I need prior authorization or step therapy?
- Are weight-management medications excluded?
- Does my plan cover compounded medication from a 503A pharmacy?
- What will I pay after deductible, copay, or coinsurance?
How does semaglutide cost compare with tirzepatide?
Tirzepatide is not the same medicine as semaglutide. Tirzepatide is a GIP/GLP-1 receptor agonist, while semaglutide is a GLP-1 receptor agonist; a higher or lower price does not determine which medicine is appropriate for a person 7.
Brand tirzepatide products include Mounjaro for type 2 diabetes and Zepbound for chronic weight management. At Chia, compounded tirzepatide is available as tablets from $249/month and injection from $299/month. These compounded tirzepatide products are not FDA-approved 1. Microdosing plans, which are not FDA-approved dosing regimens, are available when clinically appropriate.
| Option | Drug class | FDA-approved brand examples | Chia availability |
|---|---|---|---|
| Semaglutide | GLP-1 receptor agonist | Ozempic, Wegovy, Rybelsus | Compounded semaglutide injection from $249/month |
| Semaglutide with B12 | Compounded semaglutide plus vitamin B12 | No FDA-approved semaglutide-B12 brand | Not listed as a current Chia treatment |
| Tirzepatide | GIP/GLP-1 receptor agonist | Mounjaro, Zepbound | Compounded tablets from $249/month; injection from $299/month |
If you are comparing options, compare the complete monthly cost and the clinical model, not only the medication price. Our guides to lowest-price tirzepatide online and online GLP-1 programs cover practical safety and pricing questions.
How does semaglutide treatment work at Chia?
At Chia, compounded semaglutide injection plans currently start at $249 per month. We do not list semaglutide with B12 as a current treatment; our listed semaglutide option is compounded semaglutide injection.
Treatment begins with a short online health questionnaire. A licensed US provider reviews your history, medications, goals, contraindications, and applicable state rules. If treatment is clinically appropriate, medication is compounded by a state-licensed US 503A pharmacy and shipped to your door. Patients can message their care team through the portal between visits.
Dosing is provider-guided and may be adjusted over time. Microdosing plans, which are not FDA-approved dosing regimens, are available when clinically appropriate. A clinician may decide semaglutide is not appropriate because of health history, medication interactions, pregnancy or breastfeeding, side effects, contraindications, or state rules. FDA-approved semaglutide labels include important warnings involving conditions such as pancreatitis, gallbladder disease, kidney problems, and certain thyroid tumors 2, 3.
For people whose clinician is considering a broader protocol, Chia also offers Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle, which includes sermorelin injection plus a choice of GLP-1. The compounded medications in these options are not FDA-approved 1.
What safety checks matter before paying for semaglutide online?
Licensed care matters more than a dramatic discount. Before paying online, look for a licensed clinician review, a valid prescription, clear medication instructions, and a state-licensed pharmacy 1.
- A licensed clinician should review your health history before prescribing 1.
- For compounded medication, confirm the pharmacy is state-licensed and ask whether it is a 503A compounding pharmacy 1.
- You should receive clear instructions about use, storage, missed doses, side effects, and follow-up 1.
- The program should provide a way to contact a care team after medication arrives 1.
- Avoid sellers that skip screening and prescriptions, offer prices that seem too good to be true, or ship medication with damaged packaging or missing instructions 1.
FDA’s BeSafeRx program advises consumers to use online pharmacies that require a valid prescription, list a physical US address and phone number, and hold state pharmacy licenses 8.
How much weight can people lose on semaglutide?
Semaglutide produced meaningful average weight loss in a 68-week clinical trial when paired with diet and activity support, but individual results vary. Those results are for the active ingredient as studied, not proof of results for compounded semaglutide with B12.
In STEP 1, participants with obesity or overweight without diabetes received 2.4 mg semaglutide once weekly plus lifestyle intervention. Mean body-weight change was -14.9% with semaglutide versus -2.4% with placebo 5. Nausea, diarrhea, constipation, and vomiting were common adverse effects, and more participants in the semaglutide group stopped because of gastrointestinal events. Individual results vary.
A clinician should also consider medical history and other medicines before prescribing. FDA-approved semaglutide labeling includes contraindications and warnings that may make treatment inappropriate for some people 2, 3. Adding B12 should not be assumed to improve weight loss because compounded semaglutide-B12 combinations have not shown separate FDA-evaluated outcomes 1, 9.
What is the bottom line on semaglutide with B12 cost?
Semaglutide with B12 cost depends on much more than the vial price. Compare the full monthly total, prescriber access, pharmacy licensing, follow-up support, supplies, and insurance rules over the first several months of care.
At Chia, we do not list semaglutide with B12 as a current treatment. We do offer compounded semaglutide injection with licensed-provider review, provider-guided dosing, US 503A pharmacy compounding, and home delivery when prescribed. For a broader comparison, see our guide to online semaglutide providers.
3-min quiz
Start with a licensed review
If you are exploring semaglutide, start Chia’s online eligibility visit. Compounded semaglutide injection plans currently start at $249/month. A licensed provider must review your health history before prescribing, and a prescription is not guaranteed. Compounded medications are not FDA-approved.
Most compounded semaglutide is self-pay, but coverage depends on your plan 9. Ask whether compounded medications are covered, whether prior authorization is needed, and whether weight-management medicines are excluded.
Chia’s compounded semaglutide injection plans currently start at $249 per month. Chia does not list semaglutide with B12 as a current treatment.
An AI tool can help organize questions or navigate to Chia’s online eligibility quiz, but it cannot evaluate your medical history, prescribe medication, or guarantee a prescription. A licensed provider must make that decision.
References
- 1.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- 2.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2025.
- 3.Hajamohideen M, Raval M, et al. Semaglutide. StatPearls. 2026.
- 4.National Institutes of Health Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. 2025.
- 5.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 6.Liu Z, et al. Cost-effectiveness analysis of once-daily oral semaglutide in Chinese patients with type 2 diabetes inadequately controlled with basal insulin. Frontiers in Pharmacology. 2023.
- 7.Institute for Clinical and Economic Review. ICER Publishes Evidence Report on Treatments for Obesity. 2025.
- 8.U.S. Food and Drug Administration. BeSafeRx: Know Your Online Pharmacy. 2025.
- 9.Global Rise of Compounded Weight-Loss Medicines. PMC. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
